BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,068,125 shares; 2025Q1: 6,068,125 shares; 2025Q2: 6,068,125 shares; 2025Q3: 6,089,611 shares; 2025Q4: 5,089,611 shares; 2026Q1: 5,089,611 shares; 2026Q2: 4,589,611 shares; 2026Q3: 3,089,611 shares 3,089,611 $203M 67.92% -1,500,000 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,025,000 shares; 2025Q1: 1,025,000 shares; 2025Q2: 1,316,806 shares; 2025Q3: 1,316,806 shares; 2025Q4: 1,316,806 shares; 2026Q1: 1,316,806 shares; 2026Q2: 1,316,806 shares; 2026Q3: 1,316,806 shares 1,316,806 $24.8M 8.27% 0 Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 964,500 shares; 2025Q1: 1,198,418 shares; 2025Q2: 1,198,418 shares; 2025Q3: 1,198,418 shares; 2025Q4: 1,198,418 shares; 2026Q1: 1,432,336 shares; 2026Q2: 1,432,336 shares; 2026Q3: 1,732,336 shares 1,732,336 $21.6M 7.2% +300,000 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,472,331 shares; 2025Q1: 1,472,331 shares; 2025Q2: 1,472,331 shares; 2025Q3: 1,472,331 shares; 2025Q4: 1,472,331 shares; 2026Q1: 1,555,664 shares; 2026Q2: 1,555,664 shares; 2026Q3: 1,555,664 shares 1,555,664 $18.6M 6.2% 0 Timeline BCAX BICARA THERAPEUTICS INC More: the full row for BICARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 568,919 shares; 2025Q1: 568,919 shares; 2025Q2: 568,919 shares; 2025Q3: 568,919 shares; 2025Q4: 568,919 shares; 2026Q1: 568,919 shares; 2026Q2: 568,919 shares; 2026Q3: 548,919 shares 548,919 $10.2M 3.41% -20,000 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 108,000 shares; 2026Q1: 108,000 shares; 2026Q2: 108,000 shares; 2026Q3: 108,000 shares 108,000 $4.39M 1.47% 0 Timeline BBOT BRIDGEBIO ONCOLOGY THERAPEUT More: the full row for BRIDGEBIO ONCOLOGY THERAPEUT Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 564,625 shares; 2025Q4: 564,625 shares; 2026Q1: 1,018,018 shares; 2026Q2: 1,018,018 shares; 2026Q3: 1,018,018 shares 1,018,018 $4.14M 1.38% 0 Timeline EPRX EUPRAXIA PHARMACEUTICALS INC More: the full row for EUPRAXIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 325,000 shares; 2026Q2: 325,000 shares; 2026Q3: 325,000 shares 325,000 $2.96M 0.99% 0 Timeline BMEA BIOMEA FUSION INC More: the full row for BIOMEA FUSION INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 798,757 shares; 2025Q1: 798,757 shares; 2025Q2: 2,048,757 shares; 2025Q3: 2,048,757 shares; 2025Q4: 2,048,757 shares; 2026Q1: 2,048,757 shares; 2026Q2: 2,048,757 shares; 2026Q3: 2,048,757 shares 2,048,757 $2.74M 0.92% 0 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 434,455 shares; 2025Q1: 434,455 shares; 2025Q2: 434,455 shares; 2025Q3: 434,455 shares; 2025Q4: 434,455 shares; 2026Q1: 434,455 shares; 2026Q2: 434,455 shares; 2026Q3: 434,455 shares 434,455 $2.29M 0.76% 0 Timeline SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 77,031 shares; 2025Q4: 77,031 shares; 2026Q1: 77,031 shares; 2026Q2: 77,031 shares; 2026Q3: 42,031 shares 42,031 $2.03M 0.68% -35,000 Timeline VTVT VTV THERAPEUTICS INC More: the full row for VTV THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 58,775 shares 58,775 $1.81M 0.61% +8,775 Timeline MRKR MARKER THERAPEUTICS INC More: the full row for MARKER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 325,370 shares; 2025Q1: 325,370 shares; 2025Q2: 325,370 shares; 2025Q3: 325,370 shares; 2025Q4: 325,370 shares; 2026Q1: 325,370 shares; 2026Q2: 325,370 shares; 2026Q3: 325,370 shares 325,370 $348K 0.12% 0 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 88,607 shares; 2025Q1: 88,607 shares; 2025Q2: 88,607 shares; 2025Q3: 88,607 shares; 2025Q4: 88,607 shares; 2026Q1: 88,607 shares; 2026Q2: 88,607 shares; 2026Q3: 88,607 shares 88,607 $241K 0.08% 0 Timeline